Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Suparma Tbk PT stock

SPMA.JK
ID1000054307

Price

0
Today +/-
-0
Today %
-0 %

Suparma Tbk PT stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Suparma Tbk PT stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Suparma Tbk PT stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Suparma Tbk PT stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Suparma Tbk PT's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Suparma Tbk PT Stock Price History

DateSuparma Tbk PT Price
12/16/20240 undefined
12/13/20240 undefined
12/12/20240 undefined
12/11/20240 undefined
12/10/20240 undefined
12/9/20240 undefined
12/6/20240 undefined
12/5/20240 undefined
12/4/20240 undefined
12/3/20240 undefined
12/2/20240 undefined
11/29/20240 undefined
11/28/20240 undefined
11/26/20240 undefined
11/25/20240 undefined
11/22/20240 undefined
11/21/20240 undefined
11/20/20240 undefined
11/19/20240 undefined
11/18/20240 undefined

Suparma Tbk PT Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Suparma Tbk PT, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Suparma Tbk PT from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Suparma Tbk PT’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Suparma Tbk PT. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Suparma Tbk PT’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Suparma Tbk PT’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Suparma Tbk PT’s growth potential.

Suparma Tbk PT Revenue, EBIT and net profit per share

DateSuparma Tbk PT RevenueSuparma Tbk PT EBITSuparma Tbk PT Net Income
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined

Suparma Tbk PT Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
000000000000000000000000
------------------------
------------------------
000000000000000000000000
000000000000000000000000
------------------------
000000000000000000000000
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Suparma Tbk PT Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Suparma Tbk PT is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                               
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
                                               
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
000000000000000000000000
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Suparma Tbk PT provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Suparma Tbk PT's financial health and stability.

Assets

Suparma Tbk PT's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Suparma Tbk PT must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Suparma Tbk PT after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Suparma Tbk PT's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000
-----------------------
00000000000000000000000
00000000000000000000000
00000000000000000000000
00000000000000000000000

Suparma Tbk PT stock margins

The Suparma Tbk PT margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Suparma Tbk PT. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Suparma Tbk PT.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Suparma Tbk PT's sales revenue. A higher gross margin percentage indicates that the Suparma Tbk PT retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Suparma Tbk PT's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Suparma Tbk PT's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Suparma Tbk PT's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Suparma Tbk PT. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Suparma Tbk PT's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Suparma Tbk PT Margin History

Suparma Tbk PT Gross marginSuparma Tbk PT Profit marginSuparma Tbk PT EBIT marginSuparma Tbk PT Profit margin
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %
20060 %0 %0 %
20050 %0 %0 %
20040 %0 %0 %

Suparma Tbk PT Stock Sales Revenue, EBIT, Earnings per Share

The Suparma Tbk PT earnings per share therefore indicates how much revenue Suparma Tbk PT has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Suparma Tbk PT earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Suparma Tbk PT's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Suparma Tbk PT’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Suparma Tbk PT's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Suparma Tbk PT Revenue, EBIT and net profit per share

DateSuparma Tbk PT Sales per ShareSuparma Tbk PT EBIT per shareSuparma Tbk PT Earnings per Share
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined

Suparma Tbk PT business model

The Indonesian company Suparma Tbk PT has a history of over 4 decades. It was founded in 1976 and has since become one of the largest paper bag manufacturers in the country. The company's business model is primarily based on the production and distribution of paper bags and packaging. They produce various types of paper bags, such as carrier bags, takeaway boxes, and food packaging, using both recycled and new paper. Another important aspect of Suparma Tbk PT is the production of Kraftliner and Testliner papers, which are used for packaging and cardboard manufacturing. The company uses modern machines and high-quality standards to provide the best possible quality to its customers. Suparma Tbk PT is also active in the field of renewable energy, operating a biogas plant in one of its factories since 2018. This enables them to convert waste from paper production into energy and contribute to environmental sustainability. The products of Suparma Tbk PT are distributed both domestically and internationally, and the company is able to offer customized solutions to meet the growing demand for environmentally friendly packaging and products. Overall, Suparma Tbk PT is a company with a diversified business model, active not only in the production of paper bags and packaging but also in other areas. They have a strong focus on sustainability and environmental protection, which is highly commendable considering the global challenges in this field. Suparma Tbk PT is one of the most popular companies on Eulerpool.com.

Suparma Tbk PT SWOT Analysis

Strengths

  • Established company with a long history in the paper manufacturing industry.
  • Strong brand recognition and reputation in the market.
  • Diverse product portfolio catering to various customer needs.

Weaknesses

  • Reliance on raw material suppliers for paper production.
  • Limited global presence compared to competitors.
  • High energy costs impacting profitability.

Opportunities

  • Growing demand for eco-friendly and sustainable paper products.
  • Expansion into emerging markets with untapped potential.
  • Innovative product development to cater to changing consumer preferences.

Threats

  • Intense competition from both local and international paper manufacturers.
  • Fluctuating raw material prices affecting production costs.
  • Increasing environmental regulations and sustainability standards.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Suparma Tbk PT Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Suparma Tbk PT historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Suparma Tbk PT shares outstanding

The number of shares was Suparma Tbk PT in 2023 — This indicates how many shares 3.154 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Suparma Tbk PT earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Suparma Tbk PT's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Suparma Tbk PT’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Suparma Tbk PT's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Suparma Tbk PT stock splits

In Suparma Tbk PT's history, there have been no stock splits.
Suparma Tbk PT does not pay out any dividends.
Suparma Tbk PT does not pay out any dividends.
Suparma Tbk PT does not pay out any dividends.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Suparma Tbk PT.

Suparma Tbk PT shareholders

%
Name
Stocks
Change
Date
31.48165 % PT Gloriajaya Gempita992,959,45706/30/2024
24.99973 % PT Wahana Bumi Indonesia788,514,00006/30/2024
18.00504 % Cathay Utima Investment Pte Ltd567,895,06006/30/2024
17.77255 % PT Sari Bumi Indopower560,562,18506/30/2024
0.03465 % Niche Asset Management Limited1,093,00009/30/2024
1

Most common questions regarding Suparma Tbk PT

What values and corporate philosophy does Suparma Tbk PT represent?

Suparma Tbk PT represents values of integrity, innovation, and customer satisfaction. The company's corporate philosophy focuses on delivering high-quality products and services to meet the needs of its customers. Suparma Tbk PT strives to continuously innovate and improve its processes to stay ahead in the competitive market. With a strong emphasis on integrity, the company aims to operate ethically and maintain transparent business practices. Through its commitment to excellence and customer-centric approach, Suparma Tbk PT establishes itself as a reliable and trusted provider in the industry.

In which countries and regions is Suparma Tbk PT primarily present?

Suparma Tbk PT is primarily present in Indonesia.

What significant milestones has the company Suparma Tbk PT achieved?

Suparma Tbk PT has achieved several significant milestones throughout its history. One notable milestone was its establishment in 1976 as a leading paper and stationery manufacturer in Indonesia. Over the years, the company has expanded its product portfolio and diversified its business segments, becoming a trusted name in the industry. In 2001, Suparma Tbk PT went public and successfully listed its shares on the Indonesia Stock Exchange (IDX), marking a major milestone in its corporate journey. With a strong commitment to innovation, quality assurance, and sustainable practices, Suparma Tbk PT continues to thrive and deliver value to its stakeholders.

What is the history and background of the company Suparma Tbk PT?

Suparma Tbk PT, established in 1976, is a reputable Indonesian company specializing in paper manufacturing. With a rich history spanning over four decades, Suparma Tbk PT has grown into one of the leading producers of high-quality paper products in the country. The company focuses on producing uncoated woodfree paper, which is widely used for various purposes such as printing books, magazines, and stationery. Suparma Tbk PT has garnered a strong market presence, serving both domestic and international customers. With a commitment to innovation and sustainability, Suparma Tbk PT continues to thrive in the paper industry, contributing to economic growth and environmental preservation.

Who are the main competitors of Suparma Tbk PT in the market?

The main competitors of Suparma Tbk PT in the market include other prominent paper manufacturing companies such as Asia Pulp & Paper Co. Ltd, PT Indah Kiat Pulp & Paper Tbk, and PT Pabrik Kertas Tjiwi Kimia Tbk. These competitors operate within the same industry and offer similar products and services. Their presence and competition contribute to shaping Suparma Tbk PT's market position and drive the company to continuously innovate and differentiate itself in order to maintain a competitive edge.

In which industries is Suparma Tbk PT primarily active?

Suparma Tbk PT is primarily active in the paper and packaging industry.

What is the business model of Suparma Tbk PT?

The business model of Suparma Tbk PT revolves around the production and distribution of various paper products. As a leading paper manufacturer in Indonesia, Suparma Tbk PT specializes in producing high-quality paper, including tissue paper, packaging paper, and specialty paper products. The company operates with a vertically integrated approach, encompassing the sourcing of raw materials, manufacturing processes, and delivery to customers. Through continuous innovation and commitment to quality, Suparma Tbk PT aims to meet the diverse needs of its customers while maintaining environmental sustainability. With its strong market presence and robust production capabilities, Suparma Tbk PT strives to be a trusted and reliable provider of paper solutions in the industry.

What is the P/E ratio of Suparma Tbk PT 2024?

The P/E ratio cannot be calculated for Suparma Tbk PT at the moment.

What is the P/S ratio of Suparma Tbk PT 2024?

The P/S cannot be calculated for Suparma Tbk PT currently.

What is the Quality Investing of Suparma Tbk PT?

The Quality Investing for Suparma Tbk PT is 4/10.

What is the revenue of Suparma Tbk PT 2024?

The revenue cannot currently be calculated for Suparma Tbk PT.

How high is the profit of Suparma Tbk PT 2024?

The profit cannot currently be calculated for Suparma Tbk PT.

What is the business model of Suparma Tbk PT

Suparma Tbk PT is a leading company in the paper industry in Indonesia and one of the largest in Asia. The company was established in 1976 and is based in Surabaya, Indonesia. Suparma Tbk PT is a vertically integrated company that serves various sectors, including the production of paper products, tissues, and packaging. Answer: Suparma Tbk PT is a leading company in the paper industry in Indonesia and one of the largest in Asia. It was established in 1976 and is based in Surabaya, Indonesia. The company serves various sectors, including the production of paper products, tissues, and packaging.

What is the Suparma Tbk PT dividend?

Suparma Tbk PT pays a dividend of 0 IDR distributed over payouts per year.

How often does Suparma Tbk PT pay dividends?

The dividend cannot currently be calculated for Suparma Tbk PT or the company does not pay out a dividend.

What is the Suparma Tbk PT ISIN?

The ISIN of Suparma Tbk PT is ID1000054307.

What is the Suparma Tbk PT ticker?

The ticker of Suparma Tbk PT is SPMA.JK.

How much dividend does Suparma Tbk PT pay?

Over the past 12 months, Suparma Tbk PT paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Suparma Tbk PT is expected to pay a dividend of 0 IDR.

What is the dividend yield of Suparma Tbk PT?

The current dividend yield of Suparma Tbk PT is .

When does Suparma Tbk PT pay dividends?

Suparma Tbk PT pays a quarterly dividend. This is distributed in the months of August, July, July, July.

How secure is the dividend of Suparma Tbk PT?

Suparma Tbk PT paid dividends every year for the past 0 years.

What is the dividend of Suparma Tbk PT?

For the upcoming 12 months, dividends amounting to 0 IDR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Suparma Tbk PT located?

Suparma Tbk PT is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Suparma Tbk PT kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Suparma Tbk PT from 7/8/2024 amounting to 12 IDR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Suparma Tbk PT pay the last dividend?

The last dividend was paid out on 7/8/2024.

What was the dividend of Suparma Tbk PT in the year 2023?

In the year 2023, Suparma Tbk PT distributed 10.056 IDR as dividends.

In which currency does Suparma Tbk PT pay out the dividend?

The dividends of Suparma Tbk PT are distributed in IDR.

All fundamentals about Suparma Tbk PT

Our stock analysis for Suparma Tbk PT Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Suparma Tbk PT Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.